Scribd
Upload
140 views2 pages

Lotader: Ethylene - Glycidyl Methacrylate Copolymer

Uploaded by

julius hasan33
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
140 views2 pages

Lotader: Ethylene - Glycidyl Methacrylate Copolymer

Uploaded by

julius hasan33
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

LOTADER® AX8840

Ethylene - Glycidyl Methacrylate copolymer

DESCRIPTION
LOTADER® AX8840 is a random copolymer of ethylene and glycidyl methacrylate, polymerized by high-
pressure autoclave process.
 Glycidyl methacrylate gives reactivity (versus OH, COOH and NH2 groups), leading to optimal
dispersion during melt mixing with engineering thermoplastics.
 As an ethylene copolymer, LOTADER® AX8840 is compatible with LDPE in all proportions, and
with almost all other ethylene copolymers.
 LOTADER® AX8840 exhibits good adhesion on PET, PBT, PPS, metal, paper, glass.

TYPICAL PROPERTIES

Characteristics Value Unit Test Method

Glycidyl Methacrylate content 8 % Wt FTIR (internal method)


Melt Index (190°C / 2.16 kg) 5 g/10min ISO 1133 / ASTM D1238
Melting point 104 °C ISO 11357-3
Density 0.94 g/cm3 ISO 1183 / ASTM D1505
Vicat softening temperature (10N) (1) 87 °C ISO 306 / ASTM D1525
Flexural modulus (1) 85 MPa ISO 178 / ASTM D790
Elongation at break (1) 400 % ISO 527-2 / ASTM D638
Tensile strength at break (1) 8 MPa ISO 527-2 / ASTM D638
Hardness Shore D (at 1s) (1) 50 ISO 868 / ASTM D2240
(1) On compression molded samples.

APPLICATIONS
Due to its reactivity induced by the glycidyl methacrylate, LOTADER® AX8840 can be use as a
compatibilizer for polyesters/polyolefins blends and as an adhesive for some laminate structures
(polyolefins/polyesters, polyolefins/PPS etc.).

For more detailed information and recommendations regarding your specific application, please contact
your local ARKEMA technical representative.


LOTADER® AX8840

PROCESSING
Heat stability of acrylate comonomer allows processing temperatures as high as for polyesters (PBT, PET)
and PPS, which is the main material using LOTADER® AX8840 as impact modifier or compatibilizer.
CAUTION: LOTADER® AX8840 reacts with polymers containing maleic anhydride and acid. This reaction
may generate gels or can block an extruder if not controlled. Extruders must be thoroughly purged before
and after extruding LOTADER® AX8840.

STORAGE, HANDLING AND SAFETY


LOTADER® AX8840 should be stored in dry conditions and be kept out of moisture in an aerated building.
Improper storage conditions may cause degradation and could have consequences on physical properties
of the product.

Safety data sheet as well as information on handling and storage of the LOTADER® AX8840 is available
upon request to your ARKEMA representative or on the web site lotader.com.

SHELF LIFE
Two years from the date of delivery, in unopened packaging. For any use above this limit, please refer to
our technical services.

February 2018

The statements, technical information and recommendations contained herein are believed to be accurate as of the date hereof. Since the conditions and methods
of use of the product and of the information referred to herein are beyond our control, ARKEMA expressly disclaims any and all liability as to any results obtained
or arising from any use of the product or reliance on such information; NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF
MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE GOODS DESCRIBED OR THE INFORMATION PROVIDED
HEREIN.
The information provided herein relates only to the specific product designated and may not be applicable when such product is used in combination with other
materials or in any process. The user should thoroughly test any application before commercialization. Nothing contained herein constitutes a license to practice

ARKEMA Société anonyme au capital de 614 937 940 euros - 445 074 685 RCS Nanterre
under any patent and it should not be construed as an inducement to infringe any patent and the user is advised to take appropriate steps to be sure that any
proposed use of the product will not result in patent infringement. See SDS for Health & Safety Considerations. Arkema has implemented a Medical Policy regarding
the use of Arkema products in Medical Devices applications that are in contact with the body or circulating bodily fluids:
http://www.arkema.com/en/social-responsibility/responsible-product-management/medical-devicepolicy/index.html
Arkema has designated Medical grades to be used for such Medical Device applications. Products that have not been designated as Medical grades are not authorized
by Arkema for use in Medical Device applications that are in contact with the body or circulating bodily fluids. In addition, Arkema strictly prohibits the use of any
Arkema products in Medical Device applications that are implanted in the body or in contact with bodily fluids or tissues for greater than 30 days. The Arkema
trademarks and the Arkema name shall not be used in conjunction with customers' medical devices, including without limitation, permanent or temporary implantable
devices, and customers shall not represent to anyone else, that Arkema allows, endorses or permits the use of Arkema products in such medical devices.
It is the sole responsibility of the manufacturer of the medical device to determine the suitability (including biocompatibility) of all raw materials, products and
components, including any medical grade Arkema products, in order to ensure that the final end-use product is safe for its end use; performs or functions as
intended; and complies with all applicable legal and regulatory requirements (FDA or other national drug agencies) It is the sole responsibility of the manufacturer
of the medical device to conduct all necessary tests and inspections and to evaluate the medical device under actual end-use requirements and to adequately advise
and warn purchasers, users, and/or learned intermediaries (such as physicians) of pertinent risks and fulfill any post market surveillance obligations. Any decision
regarding the appropriateness of a particular Arkema material in a particular medical device should be based on the judgment of the manufacturer, seller, the
competent authority, and the treating physician.
Any claim relating to defects or non-compliance of the products shall be valid only if it is sent to Arkema in writing within fifteen (15) calendar days following delivery
of the Product.

Arkema Functional Polyolefins


420, rue d’Estienne d’Orves
92705 Colombes Cedex - France
arkema.com – lotader.com

You might also like